Triple
T22692766
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | 5q13 (SMN1) |
E561092
|
entity |
| Predicate | isTargetOfTherapy |
P113308
|
FINISHED |
| Object | antisense oligonucleotide therapy via SMN2 modulation |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: antisense oligonucleotide therapy via SMN2 modulation | Statement: [5q13 (SMN1), isTargetOfTherapy, antisense oligonucleotide therapy via SMN2 modulation]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: isTargetOfTherapy Context triple: [5q13 (SMN1), isTargetOfTherapy, antisense oligonucleotide therapy via SMN2 modulation]
-
A.
hasTherapeuticGoal
Indicates that an action, treatment, or intervention is undertaken with the intention of achieving a specific therapeutic or health-related outcome.
-
B.
typeOfAdvancedTherapiesAssessed
Indicates that an entity has evaluated or examined specific kinds of advanced therapies (such as gene, cell, or tissue-based treatments).
-
C.
treatmentIndication
chosen
Indicates that a treatment is intended to address, alleviate, or prevent a particular condition, symptom, or medical indication.
-
D.
hasNoApprovedDrugTreatment
Indicates that there is currently no officially approved drug-based treatment available for the condition or situation in question.
-
E.
knownForIssuerTherapies
Indicates that an issuer is recognized or notable for providing or developing specific therapies.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454d71b48190a1f80af9f82b6fcf |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1789ba0148190891781d05ec64f3c |
completed | April 29, 2026, 3:18 a.m. |
| PD | Predicate disambiguation | batch_69ee62b2259c819091ed1387a748b9f3 |
completed | April 26, 2026, 7:08 p.m. |
Created at: April 17, 2026, 3:13 p.m.